Skip to Main Content

Paper Details

Preferences of Persons With or at Risk for Hepatitis C for Long-Acting Treatments.
Clin Infect Dis
5
2022
Author NameAffiliation
Gregory D KirkThe Johns Hopkins University School of Medicine
Gregory D KirkThe Johns Hopkins Bloomberg School of Public Health
Mark S SulkowskiThe Johns Hopkins University School of Medicine
Richard E RothmanThe Johns Hopkins University School of Medicine
Yu-Hsiang HsiehThe Johns Hopkins University School of Medicine
Susan SwindellsThe University of Nebraska Medical Center
  • 1 - 6

Datasets

Release 1.2